How much funding has Inventiva Pharma raised?

Inventiva Pharma has raised $232.0M in total funding, most recently a Growth Equity round.

When was Inventiva Pharma founded?

Inventiva Pharma was founded in 2010.

Where is Inventiva Pharma headquartered?

Inventiva Pharma is headquartered in Daix, France.

What industry is Inventiva Pharma in?

Inventiva Pharma operates in Biopharmaceutical, MASH Treatment, Biotech, Healthcare.

How many employees does Inventiva Pharma have?

Inventiva Pharma has 51-200 employees.

Inventiva Pharma

IPO

Public · Daix, France · Founded 2010 · $232.0M raised

Biopharmaceutical

MASH Treatment

Biotech

Healthcare

Headquarters: Daix
Employees: 51–200
Founded: 2010
Business Model: B2B
Website: inventivapharma.com

Total Funding: $232.0M
Last Round: $116.0M Growth EquityMay 2025
Rounds: 3
Type: Public

About

Inventiva is a clinical-stage biopharmaceutical company focused on developing oral small molecule therapies for patients with significant unmet medical needs in fibrosis, lysosomal storage disorders, and oncology. Its lead candidate, lanifibranor, is a pan-PPAR agonist in Phase 3 trials for NASH/MASH with breakthrough therapy designation from the FDA. The company has built an extensive proprietary molecule library and wholly-owned R&D capabilities inherited from Abbott, Solvay, and Fournier.

Summary

Inventiva Pharma is a Biopharmaceutical company based in Daix, France, founded in 2010. It has raised $232.0M in total across 3 rounds, most recently a $116.0M Growth Equity round in May 2025.

LinkedIn X (Twitter)